As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...
Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease, the road to a cure seems long and uncertain. But as the year comes to a close, experts are ...
Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...